Iwanka Kozarewa

Oncology R&D
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Nature's Master of Ceremony: The Populus Circadian Clock as Orchestratot of Tree Growth and Phenology.

Nature's Master of Ceremony: The Populus Circadian Clock as Orchestratot of Tree Growth and Phenology.

Journal: Npj biological timing and sleep

Published: September 02, 2024

ZEITLUPE Promotes ABA-Induced Stomatal Closure in Arabidopsis and Populus.

ZEITLUPE Promotes ABA-Induced Stomatal Closure in Arabidopsis and Populus.

Journal: Frontiers in plant science

Published: December 04, 2021

Homologous Recombination Repair Gene Mutation Characterization by Liquid Biopsy: A Phase II Trial of Olaparib and Abiraterone in Metastatic Castrate-Resistant Prostate Cancer.

Homologous Recombination Repair Gene Mutation Characterization by Liquid Biopsy: A Phase II Trial of Olaparib and Abiraterone in Metastatic Castrate-Resistant Prostate Cancer.

Journal: Cancers

Published: October 20, 2021

Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer.

Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 20, 2021

An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer.

An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer.

Journal: Nature medicine

Published: May 29, 2020

Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study.

Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study.

Journal: The Lancet. Oncology

Published: February 28, 2020

Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations.

Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations.

Journal: JCO precision oncology

Published: October 03, 2019

Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial.

Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial.

Journal: Cancer discovery

Published: April 14, 2019

Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial.

Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 13, 2019

Circadian clock components control daily growth activities by modulating cytokinin levels and cell division-associated gene expression in Populus trees.

Circadian clock components control daily growth activities by modulating cytokinin levels and cell division-associated gene expression in Populus trees.

Journal: Plant, cell & environment

Published: June 30, 2017

Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells.

Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells.

Journal: Scientific data

Published: July 05, 2016

Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer.

Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer.

Journal: Science translational medicine

Published: November 13, 2015

Showing 1-12 of 33

Last Updated: 09/26/2026